Rasagiline - Parkinson's disease (neuroprotective therapy)
You are here : Home > Formulary Search > Rasagiline - Parkinson's disease (neuroprotective therapy)
I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.
Documentation
Guidelines (National)
PAD Profile
ChemicalSubstance :
Rasagiline
Indication :
Parkinson's disease (neuroprotective therapy)
Group Name :
Keywords :
dopamine agonists, Parkinsons disease, PD, monoamine-oxidase-B inhibitors, MAOB
Brand Names Include :
Azilect
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1
Other Indications
Below are listed other indications that Rasagiline is used to treat.
- No records returned.
Other Drugs
Below are listed other drugs that are used to treat Parkinson's disease (neuroprotective therapy).
Committee Recommendations (1)
Monoamine-oxidase-B inhibitors (rasagiline, selegiline) are not recommended as a neuroprotective therapy except in the context of a clinical trial.